FluidAI Medical’s Origin™, an inline bio-sensing system for real-time, bedside monitoring of surgical effluent, has received FDA 510(k) clearance in the United States. This milestone marks a major leap forward in transforming post-operative recovery through data-driven, intelligent care. Origin™ connects seamlessly to standard surgical drains and delivers continuous pH data visualization turning what was once an intermittent measurement into a real-time signal that empowers clinicians to detect subtle biochemical shifts.

FluidAI will soon reach another important milestone, by supporting patients across 100,000 total operations.

Learn more about how FluidAI is redefining surgical care through real-time data and intelligent insights from Ricky Tjandra, Director of Research at FluidAI Medical…(Read more).

Published on November 19, 2025
Originally published by Velocity
Image credit: Velocity